Funder
Nippon Foundation
Kobayashi Foundation for Cancer Research
Takeda Science Foundation
Japan Agency for Medical Research and Development
Mitsubishi Foundation
Japan Society for the Promotion of Science
Reference51 articles.
1. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Mayo Clin. Proc.,2008
2. Discovery stories of RET fusions in lung cancer: a mini-review;Takeuchi;Front. Physiol.,2019
3. Clinical and translational implications of RET rearrangements in non-small cell lung cancer;Ferrara;J. Thorac. Oncol.,2018
4. Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas;Drilon;Cancer Discov.,2013
5. Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial;Drilon;Lancet Oncol.,2016